Anesthetic Effect – Pipeline Review, 2019

Anesthesia refers to a medical procedure where a state of controlled and temporary loss of consciousness and sensation or awareness is induced for medical purposes. Despite the extremely commonplace usage of anesthesia for a variety of medical purposes, the method in which anesthesia induces loss of consciousness is still not fully understood. Anesthesia is critical for the undertaking painless operations and brings in a reversible state of medically induced coma. Some of the types of anesthesia are general anesthesia, regional anesthesia, combined general and epidural anesthesia and monitored anesthesia care with conscious sedation.

Anesthesia can be administered in a variety of techniques such as intravenously, through inhalation or through injection. Some of the common side effects of anesthesia effect include temporary memory loss and confusion, difficulty in urination, dizziness, pain, and soreness from the IV insertion, nausea, vomiting, sore throat, and shivering. The process of anesthesia effect is often undertaken through four stages: stage 1 (induction), stage 2 (excitement stage), stage 3 (surgical anesthesia) and stage 4 (overdose).

Pharmaceutical companies along with various research institutes have been focusing on studying and developing new treatment options for Anesthetic Effect. For instance; Remimazolam (CNS7056), which is being studied by Paion UK Ltd., is currently in phase-3 clinical trials for the Efficacy and Safety of Remimazolam (CNS7056) Compared to Propofol for Intravenous Anesthesia During Elective Surgery.

At present, around 78% of the pipeline candidates for Anesthetic Effect are in the phase-2 and phase-4 stage combined. Majority of the studies are sponsored by industry and governmental research institutions.

Report Description

The report on ‘Anesthetic Effect – Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for Anesthetic Effect. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for Anesthetic Effect.

The report on ‘Anesthetic Effect – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.

Report Scope

•  A thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target
• Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration
• Overview of dormant and discontinued pipeline products
• Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products
• Overview of the latest developments; news articles, press releases, and relevant conferences

Report Methodology

• All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.
• Desk research sources include global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases

Reasons to Buy this Report

• Develop effective growth strategies based on a comprehensive overview of the R&D activity and pipeline products for Anesthetic Effect
• Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players
• Identify the focus of leading players in relation to R&D for Anesthetic Effect
• Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business
• Analyze the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary